Ironwood Pharmaceuticals | IRWD - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Acadia Pharmaceuticals USD 1.31B 58.54M 2026-06
Agios Pharmaceuticals USD 1.03B 83.09M 2026-06
Akebia Therapeutics USD 25.02M 2.36M 2026-06
Almirall EUR 1.53B 43.26M 2026-06
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
Amarin USD 443.62M 5.8M 2026-06
Ardelyx USD 148.62M 18.33M 2026-03
Astellas Pharma JPY 1.94T 113.64B 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
Charles River Laboratories USD 2.84B 59.06M 2026-06
Coherus Biosciences USD 60.84M 17.78M 2026-06
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Halozyme Therapeutics USD 143.54M 76.09M 2026-06
Incyte USD 6.34B 721.58M 2026-06
Ironwood Pharmaceuticals USD -217.14M 44.69M 2026-03
Karyopharm Therapeutics USD -265.65M 27.28M 2026-03
Lexicon Pharmaceuticals USD 202.86M 95.32M 2026-03
MacroGenics USD 42.87M 21.68M 2026-06
Moderna USD 6.76B 647M 2026-06
Myriad Genetics USD 303.9M 33.5M 2026-06
Pacira USD 671.98M 18.08M 2026-06
PTC Therapeutics USD -165.36M 15.1M 2026-06
Puma Biotechnology USD 115.27M 10.55M 2025-09
Sarepta Therapeutics USD 1.53B 22.7M 2026-06
Takeda JPY 7.56T 215.7B 2026-06
Ultragenyx Pharmaceutical USD -291M 55M 2026-06
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12